These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 7951392

  • 21. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
    Sen N, Majumder HK.
    Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
    [Abstract] [Full Text] [Related]

  • 22. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
    Bacchi CJ, Yarlett N.
    Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
    [Abstract] [Full Text] [Related]

  • 23. [Chemotherapy of protozoal and helminthic diseases of the gastrointestinal system in Israel].
    El-On J, Karsenty E.
    Harefuah; 1984 Nov 15; 107(10):298-308. PubMed ID: 6530176
    [No Abstract] [Full Text] [Related]

  • 24. Tubulin as an antiprotozoal drug target.
    Werbovetz KA.
    Mini Rev Med Chem; 2002 Dec 15; 2(6):519-29. PubMed ID: 12370037
    [Abstract] [Full Text] [Related]

  • 25. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J.
    Parassitologia; 2004 Jun 15; 46(1-2):81-4. PubMed ID: 15305692
    [Abstract] [Full Text] [Related]

  • 26. New approaches for the identification of drug targets in protozoan parasites.
    Müller J, Hemphill A.
    Int Rev Cell Mol Biol; 2013 Jun 15; 301():359-401. PubMed ID: 23317822
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy.
    Bacchi CJ.
    J Protozool; 1981 Feb 15; 28(1):20-7. PubMed ID: 6788943
    [No Abstract] [Full Text] [Related]

  • 33. Understanding drug resistance in human intestinal protozoa.
    El-Taweel HA.
    Parasitol Res; 2015 May 15; 114(5):1647-59. PubMed ID: 25782683
    [Abstract] [Full Text] [Related]

  • 34. [Therapy of human diseases caused by protozoal parasites. II].
    Fossati C.
    Clin Ter; 1978 Nov 15; 87(3):273-99. PubMed ID: 753575
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antiprotozoan activity of nitroimidazoles.
    De Carneri I.
    Arzneimittelforschung; 1969 Mar 15; 19(3):382-6. PubMed ID: 4889732
    [No Abstract] [Full Text] [Related]

  • 37. Protein kinases as targets for anti-parasitic chemotherapy.
    Doerig C.
    Biochim Biophys Acta; 2004 Mar 11; 1697(1-2):155-68. PubMed ID: 15023358
    [Abstract] [Full Text] [Related]

  • 38. Editorial of the special issue "Parasitology in Mexico".
    Correa D, Talamás-Rohana P, Flisser A.
    Infect Genet Evol; 2009 Dec 11; 9(6):1021-2. PubMed ID: 19833231
    [No Abstract] [Full Text] [Related]

  • 39. Drug targets for the treatment of protozoan parasitic diseases.
    Guddat L.
    Curr Top Med Chem; 2011 Dec 11; 11(16):2010-1. PubMed ID: 21619516
    [No Abstract] [Full Text] [Related]

  • 40. [Basic trends and the prospects for creating new synthetic chemotherapeutic preparations].
    Pershin GN.
    Antibiotiki; 1980 Oct 11; 25(10):723-9. PubMed ID: 7425591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.